The effect and mechanism of ellagic acid on the proliferation and invasion properties of human glioma U251 cells
Dongliang Wang,Qianxue Chen,Baohui Liu,Yuntao Li,Bangkun Yang,Fanen Yuan,Peng Wu,Yinqiu Tan
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.03.022
2018-01-01
Abstract:Objective To investigate the anti-proliferation and anti-metastatic effect of ellagic acid (EA) on glioma cell line U251 and related mechanisms.Methods In this study,we employed cell counting kit-8 (CCK-8) assay to test the anti-proliferative effect of EA.Flow cytometer was used to monitor cell apoptosis and cell cycle.Wound healing assay and Transwell assay were used to test the anti-invasion effect of EA.Western blotting was employed to test the effect of EA on the expressions of B cell lymphoma/leukemia-2 (bcl-2),bcl-2 associated X protein (bax),Cysteinyl aspartate-specific protease (Caspase)-3,matrix metalloproteinase (MMP)-9 and MMP-2.Results EA could significantly inhibit the proliferation of U251 cells in concentration-dependent manner and time-dependent manner,and the concentration of half maximal inhibitory concentration (IC50) after treated 48 hours was 39.24 μg/ml.The apoptosis rate of 40 μg/ml was (34.07 ± 0.28) %,compared with control group,the difference was significant (P =0.001).Flow cytometer test shows the percentage of cells in S phase treated by EA 40 μg/ml was (47.75 ± 2.02) %,compared with control group (20.45 ± 0.28) %,the difference was significant (P =0.000).The expressions of bax and Caspase-3 were increased significantly,while bcl-2 was decreased.In Wound healing assay,when treated 24 h by EA,the wound healing rate in control group,5 μg/ml group,10 μg/ml group were (53.88 ±0.30)%,(36.82 ±0.56)% and (31.33 ± 0.24) %,the difference was significant (P =0.000,P =0.000);In Transwell assay,the number of passed cells were (168.2 ±7.1),(66.4 ± 2.5) and (38.6 ± 1.5) respectively,the difference was significant (P =0.001,P =0.000).The expressions of MMP-9 and MMP-2 were decreased significantly.Conclusion EA inhibits the proliferation and invasion of glioma cell line U251,which suggests that EA is a potential therapeutic agent for glioma.